COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D PXPX FLVFLV PVP-IPI BUBU BHBH BLBL CICI HC QHC Q NZNZ COCO More..
Vitamin D meta
5/10 Early, Late, PrEP, PEP
Covid Analysis (Preprint) (meta analysis)
Vitamin D for COVID-19: real-time meta analysis of 75 studies
Source   PDF   Share   Tweet
• 96% of 23 vitamin D treatment studies report positive effects (13 statistically significant in isolation).
• Random effects meta-analysis with pooled effects using the most serious outcome reported shows 78% and 53% improvement for early treatment and for all studies (RR 0.22 [0.12-0.43] and 0.47 [0.36-0.60]). Results are similar after restriction to 17 peer-reviewed studies: 81% and 55% (RR 0.19 [0.06-0.61] and 0.45 [0.33-0.61]).
Heterogeneity arises from many factors including treatment delay, patient population, the effect measured, variants, the form of vitamin D used, and treatment regimens. The consistency of positive results across a wide variety of cases is remarkable. The only treatment study reporting a negative effect is a very late stage cholecalciferol study.
Sufficiency studies show a strong association between vitamin D sufficiency and outcomes. Meta analysis of the 52 studies with pooled effects using the most serious outcome reported shows 53% improvement (RR 0.47 [0.40-0.55]).
• While many treatments have some level of efficacy, they do not replace vaccines and other measures to avoid infection. Only 4% of vitamin D treatment studies show zero events in the treatment arm. Multiple approaches are required to protect everyone from all existing and future variants.
• All data to reproduce this paper and the sources are in the appendix.
ImprovementStudies AuthorsPatients
Treatment RCTs 50% [14‑71%] 5 56 1,370
Treatment studies 53% [40‑64%] 23 236 23,046
Calcifediol/calcitriol treatment 62% [43‑75%] 4 43 7,095
Treatment mortality 63% [45‑75%] 14 127 8,818
Sufficiency studies 53% [45‑60%] 52 419 12,067


Details of all 96 studies
Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary; multiple approaches are required to protect all people from all existing and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.
  or use drag and drop to submit images   
Submit